Prediction and Prevention of Recurrent Preeclampsia
Authors:
- John R. BartonJBJohn R. Barton
- Baha M. SibaiBSBaha M. Sibai
- 1 August 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 112 (2) , 359-372
Abstract
Women with a history of previous preeclampsia are at increased risk of preeclampsia and other adverse pregnancy outcomes in subsequent pregnancies. The magnitude of this risk is dependent on gestational age at time of disease onset, severity of disease, and presence or absence of preexisting medical disorders. The objective in the management of these patients is to reduce risk factors by optimizing maternal health before conception and to detect obstetric complications as early as possible. This objective can be achieved by formulating a rational approach that includes preconception evaluation and counseling, early antenatal care, frequent monitoring of maternal and fetal well-being, and timely delivery. First-trimester ultrasound examination is essential for accurate dating and establishing fetal number. Laboratory studies are obtained to assess the function of different organ systems that are likely to be affected by preeclampsia and to establish a baseline for future assessment. Recent studies have confirmed that there is no single biomarker that can be clinically useful for the prediction of recurrent preeclampsia. Combinations of biomarkers and biophysical parameters appear promising, but more data are needed to confirm their use in clinical practice. Supplementation with fish oil, calcium, or vitamin C and E and the use of antihypertensives have been shown to be ineffective in the prevention of recurrent preeclampsia and are not recommended. Supplementation with low-dose aspirin may be offered on an individualized basis. Because women with previous preeclampsia are at increased risk for adverse pregnancy outcomes (preterm delivery, fetal growth restriction, abruptio placentae, and fetal death) in subsequent pregnancies, we recommend more frequent monitoring for signs and symptoms of severe hypertension or preeclampsia than that recommended for normal pregnancy. This monitoring may include more frequent prenatal visits, home blood pressure monitoring, or nursing contacts. For patients with a prior pregnancy complicated by preeclampsia with fetal growth restriction, we recommend serial ultrasound evaluation of fetal growth and amniotic fluid volume. The development of severe gestational hypertension, fetal growth restriction, or recurrent preeclampsia requires maternal hospitalization.Keywords
This publication has 91 references indexed in Scilit:
- Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infantsAmerican Journal of Obstetrics and Gynecology, 2008
- Prevention of Recurrent Fetal Growth RestrictionObstetrics & Gynecology, 2007
- Second-trimester angiogenic factors as biomarkers for future-onset preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestationsFertility and Sterility, 2007
- Dietary calcium supplementation for prevention of pre‐eclampsia and related problems: a systematic review and commentaryBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factorAmerican Journal of Obstetrics and Gynecology, 2007
- CXCL10/IP-10: A missing link between inflammation and anti-angiogenesis in preeclampsia?The Journal of Maternal-Fetal & Neonatal Medicine, 2007
- A case of partial mole and atypical type I triploidy associated with severe HELLP syndrome at 18 weeks' gestationUltrasound in Obstetrics & Gynecology, 2002
- Twin chorionicity and pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2001
- Prevention of Preeclampsia with Heparin and Antiplatelet Drugs in Women with Renal DiseaseAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1995